Figure 1. Research Method Flow Chart 9
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 12
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2027 14
Figure 4. Europe Diagnostic Specialty Antibodies Market, 2017-2027, $ mn 16
Figure 5. Impact of COVID-19 on Business 19
Figure 6. Primary Drivers and Impact Factors of Europe Diagnostic Specialty Antibodies Market 21
Figure 7. Primary Restraints and Impact Factors of Europe Diagnostic Specialty Antibodies Market 24
Figure 8. Investment Opportunity Analysis 28
Figure 9. Porter’s Fiver Forces Analysis of Europe Diagnostic Specialty Antibodies Market 31
Figure 10. Breakdown of Europe Diagnostic Specialty Antibodies Market by Type, 2020-2027, % of Revenue 35
Figure 11. Contribution to Europe 2021-2027 Cumulative Revenue by Type, Value ($ mn) and Share (%) 36
Figure 12. Europe Diagnostic Specialty Antibodies Market: Monoclonal Antibodies, 2017-2027, $ mn 37
Figure 13. Europe Diagnostic Specialty Antibodies Market: Polyclonal Antibodies, 2017-2027, $ mn 38
Figure 14. Europe Diagnostic Specialty Antibodies Market: Other Types, 2017-2027, $ mn 39
Figure 15. Breakdown of Europe Diagnostic Specialty Antibodies Market by Application, 2020-2027, % of Revenue 40
Figure 16. Contribution to Europe 2021-2027 Cumulative Revenue by Application, Value ($ mn) and Share (%) 41
Figure 17. Europe Diagnostic Specialty Antibodies Market: Oncology Diagnosis, 2017-2027, $ mn 42
Figure 18. Europe Diagnostic Specialty Antibodies Market: Hepatitis Diagnosis, 2017-2027, $ mn 43
Figure 19. Europe Diagnostic Specialty Antibodies Market: Infectious Disease Diagnosis, 2017-2027, $ mn 44
Figure 20. Europe Diagnostic Specialty Antibodies Market: Dengue Diagnostics, 2017-2027, $ mn 45
Figure 21. Europe Diagnostic Specialty Antibodies Market: Tuberculosis Diagnostics, 2017-2027, $ mn 46
Figure 22. Europe Diagnostic Specialty Antibodies Market: HIV Diagnostics, 2017-2027, $ mn 47
Figure 23. Europe Diagnostic Specialty Antibodies Market: Other Applications, 2017-2027, $ mn 48
Figure 24. Breakdown of Europe Diagnostic Specialty Antibodies Market by End User, 2020-2027, % of Revenue 49
Figure 25. Contribution to Europe 2021-2027 Cumulative Revenue by End User, Value ($ mn) and Share (%) 50
Figure 26. Europe Diagnostic Specialty Antibodies Market: Hospitals & Clinics, 2017-2027, $ mn 51
Figure 27. Europe Diagnostic Specialty Antibodies Market: Diagnostic Laboratories, 2017-2027, $ mn 52
Figure 28. Europe Diagnostic Specialty Antibodies Market: Other End Users, 2017-2027, $ mn 53
Figure 29. Breakdown of European Diagnostic Specialty Antibodies Market by Country, 2020 and 2027, % of Revenue 55
Figure 30. Contribution to Europe 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%) 56
Figure 31. Diagnostic Specialty Antibodies Market in UK, 2017-2027, $ mn 57
Figure 32. Diagnostic Specialty Antibodies Market in France, 2017-2027, $ mn 59
Figure 33. Diagnostic Specialty Antibodies Market in Germany, 2017-2027, $ mn 61
Figure 34. Diagnostic Specialty Antibodies Market in Spain, 2017-2027, $ mn 63
Figure 35. Diagnostic Specialty Antibodies Market in Italy, 2017-2027, $ mn 65
Figure 36. Diagnostic Specialty Antibodies Market in Russia, 2017-2027, $ mn 67
Figure 37. Diagnostic Specialty Antibodies Market in Rest of Europe, 2017-2027, $ mn 69
Figure 38. Growth Stage of Europe Diagnostic Specialty Antibodies Industry over the Forecast Period 71
Europe diagnostic specialty antibodies market accounted for $5,432.3 million in 2020 and will grow by 4.5% annually over 2020-2027 owing to the high number of patient pool undergoing diagnosis of HIV and growing demand for speciality diagnostics around the world, the advancements in DNA based technologies and diagnostics, and the increase in the prevalence of diseases such as infectious diseases, influenza and cancer. Highlighted with 30 tables and 38 figures, this 91-page report “Europe Diagnostic Specialty Antibodies Market 2020-2027 by Type (Monoclonal, Polyclonal, Others), Application (Oncology, Hepatitis, Infectious, Dengue), End User (Hospitals, Diagnostic Labs), and Country: Trend Outlook and Growth Opportunity” is based on a comprehensive research of the entire Europe diagnostic specialty antibodies market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2027 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe diagnostic specialty antibodies market in every aspect of the classification from perspectives of Type, Application, End User, and Country. Based on Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section. • Monoclonal Antibodies • Polyclonal Antibodies • Other Types Based on Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section. • Natural/Biological Products • Synthetic Products Based on Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section. • Oncology Diagnosis • Hepatitis Diagnosis • Infectious Disease Diagnosis • Dengue Diagnostics • Tuberculosis Diagnostics • HIV Diagnostics • Other Applications Based on End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section. • Hospitals & Clinics • Diagnostic Laboratories • Other End Users Geographically, the following national/local markets are fully investigated: • Germany • UK • France • Spain • Italy • Russia • Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2017-2027. The breakdown of key national markets by Type, Application, and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Key Players (this may not be a complete list and extra companies can be added upon request): Abbott Laboratories Abcam plc Agilent Technologies, Inc. Aytu BioScience, Inc. Becton, Dickinson and Company Bio-Rad Laboratories, Inc. Boehringer Ingelheim International GmbH Creative Diagnostics Enzo Life Sciences, Inc. F. Hoffmann-La Roche AG Merck KGaA Polymun Scientific Immunbiologische Forschung GmbH Sanofi S.A. Sartorius AG Thermo Fisher Scientific Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Read More